Cartesian Therapeutics RNAC
NASDAQ RNAC
$6.88 -0.01 (-0.15%)
At close: Nov 11, 2026 · 4:00 PM EST

Cartesian Therapeutics (RNAC) Gains from Sales and Divestitures (2015 - 2026)

Updated

Analysis

Cartesian Therapeutics (RNAC) Gains from Sales and Divestitures (2015 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Cartesian Therapeutics 210.06 Mn -304.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -221,000.00
Jun 30, 2026 162,000.00
Mar 31, 2026 59,000.00
Dec 31, 2024 -271,000.00
Mar 31, 2024 -2,000.00
Dec 31, 2023 -477,000.00
Mar 31, 2022 147,000.00
Dec 31, 2020 13,000.00
Sep 30, 2020 4,000.00
Jun 30, 2020 36,000.00
Mar 31, 2020 -1,000.00
Dec 31, 2019 -37,000.00
Sep 30, 2019 9,000.00
Jun 30, 2019 -6,000.00
Mar 31, 2019 -70,000.00
Dec 31, 2018 -4,000.00
Sep 30, 2018 63,000.00
Jun 30, 2018 22,000.00
Dec 31, 2017 -20,000.00
Sep 30, 2017 -16,000.00
API Access

Cartesian Therapeutics Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=RNAC&period=max&api_key=YOUR_API_KEY